Schema-Root.org logo

 

  cross-referenced news and research resources about

 Myrtle Potter

Myrtle Potter

is President of Commercial Operations at Genentech. She leads Genentech's commercial operations, including Sales, Marketing, Managed Care, Business Development, Commercial Development, and Decision Support and Commercial Innovation functions. She also co-chairs Genentech's Product Portfolio Committee and is charged with providing strategic and financial oversight of the company's drug development portfolio. Prior to Genentech, Ms. Potter held prominent positions at Bristol-Meyers Squibb and Merck and Company.

In 2003, Ms. Potter was named to Fortune Magazine's Top 50 Most Powerful Women in Business, and in 2002 she was named to Fortune's Most Powerful Black Executives in America list. Also in 2002, Time Magazine named Ms. Potter to its list of 15 Young Global Business Influentials with especially promising and wide-reaching careers.

Myrtle Potter

Myrtle Potter

images:  google   yahoo YouTube
spacer

updated Wed. October 26, 2016 reload page to refresh

-
On June 1, 2015, Radius announced that it engaged Myrtle Potter & Company, LLC to support the development of the future global commercial strategy for its lead investigational drug abaloparatide-SC for the potential treatment of post-menopausal ...
On June 1, 2015, Radius announced that it engaged Myrtle Potter & Company, LLC to support the development of the future global commercial strategy for its lead investigational drug abaloparatide-SC for the potential treatment of post-menopausal ...

"We are pleased to have the benefit of Myrtle Potter & Company's track record and experience as we prepare to transition Radius from a development stage company to a fully integrated commercial entity.
"We are pleased to have the benefit of Myrtle Potter & Company's track record and experience as we prepare to transition Radius from a development stage company to a fully integrated commercial entity.
Consistent with that you may have seen the announcement, Myrtle Potter & Company issued earlier today announcing that Esperion have retained their services to develop the commercialization strategies for 1002 monotherapy and 1002 fixed dose ...

Consider Myrtle Potter. She had already successfully served as president and COO at Genentech, president at Bristol-Meyers Squibb, and vice president at Merck, when one night in 2005 she began slipping into a coma at home.
Prior to joining AbbVie, Dr. Tannenbaum served as President of Myrtle Potter & Company, LLC, a global life sciences consulting and advisory firm.

Prior to joining AbbVie, Dr. Tannenbaum served as President of Myrtle Potter & Company, LLC, a global life sciences consulting and advisory firm.
Prior to joining AbbVie, Dr. Tannenbaum served as President of Myrtle Potter & Company, LLC, a global life sciences consulting and advisory firm.
On Dec 15, Insmed Incorporated (Nasdaq:INSM) announced the appointment of Myrtle Potter to its Board of Directors. Ms. Potter is currently CEO of Myrtle Potter & Company, a life sciences and healthcare advisory firm she founded in 2005. She was ...
On December 11, 2014, the Board of Directors (the "Board") of Insmed Incorporated (Nasdaq:INSM) increased the size of the Board to nine members and appointed Ms. Myrtle Potter as a director on the Board to fill such vacancy. Ms. Potter shall serve as a ...
Ms. Potter is currently CEO of Myrtle Potter & Company, a life sciences and healthcare advisory firm she founded in 2005.
15 announced the appointment of Myrtle Potter to its Board of Directors. Ms. Potter is currently CEO of Myrtle Potter & Company, a life sciences and healthcare advisory firm she founded in 2005. She was previously the President of Commercial Operations ...
On 15 December Insmed Incorporated (Nasdaq:INSM) announced the appointment of Myrtle Potter to its Board of Directors. Ms. Potter is currently CEO of Myrtle Potter & Company, a life sciences and healthcare advisory firm she founded in 2005. She was ...


spacer

 


 


 


 


 


schema-root.org

  career
   business
     myrtle potter

business people:
     advisors
     alex vanselow
     alfred sirven
     allan m. holt
     amelia fawcett
     amy domini
     andrea jung
     anne mulcahy
     arms merchants
     arthur levitt
     bankers
     bernard ebbers
     bill gates
     bob j. perry
     brokers
     capitalists
     charles koch
     christina gold
     christine poon
     clara furse
     conrad black
     consultants
     contractors
     craig newmark
     david lesar
     david o'reilly
     dawn hudson
     donald trump
     eleana benador
     ely calil
     entrepreneurs
     financiers
     fund managers
     gail berman
     gary cohen
     gary winnick
     gene w. ray
     george david
     george soros
     george yates
     haim saban
     howard hughes
     investors
     jack valenti
     james mulva
     jamie dimon
     jenny ming
     john rigas
     john sperling
     kate swann
     kathleen cox
     ken lay
     kenneth lerer
     larry flint
     lee raymond
     lester crown
     linda dillman
     lobbyists
     lois quam
     louis boccardi
     managers
     marc rich
     marc weisberg
     mark thatcher
     mary sammons
     maurice strong
     meg whitman
     mercenaries
     michael dell
     michael gross
     mitchell wade
     myrtle potter
     publicists
     publishers
     pug winokur
     ray lee hunt
     realtors
     richard cohen
     roger ailes
     roland betts
     ronald sugar
     ross pillari
     rupert murdoch
     scott richter
     scott sullivan
     sly bailey
     steve jobs
     ted turner
     tim ryan
     timothy rigas
     tycoons
     ursula burns
     val gooding
     vivienne cox
     warren buffet
     william conway
     william franke